Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore.

Journal of acquired immune deficiency syndromes (1999) - 1 Jan 2005

Hsu Li-Yang, Subramaniam Ravathi, Bacheler Lee, Paton Nicholas I

Abstract excerpt

OBJECTIVE: To determine the frequency of drug resistance mutations among antiretroviral treatment-naive and -experienced patients infected with CRF01_AE virus. DESIGN: Prospective observational study. METHODS: We recruited antiretroviral-experienced HIV-infected patients with suspected drug resistance and consecutive newly diagnosed drug-naive patients. Viral sequencing was performed using standard methods....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genes, Viral

Share to HIV Infections

Share to Mutation

Share to Singapore

Source

Identifiers

PMID: 15608517
DOI: 10.1097/00126334-200501010-00002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore.PMID 15608517Read ↗

Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.Semantic proximity Read ↗

Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern ChinaSemantic proximity Read ↗

Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.Semantic proximity Read ↗

Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China.Semantic proximity Read ↗

The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.Semantic proximity Read ↗

Genetic Characteristics of CRF01_AE Among Newly Diagnosed HIV-1-Infected 16- to 25-Year Olds in 3 Geographic Regions of Guangxi, China.Semantic proximity Read ↗

Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection.Semantic proximity Read ↗

The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strainsSemantic proximity Read ↗

Genetic Diversity and Drug Resistance of HIV-1 CRF55_01B in Guangdong, China.Semantic proximity Read ↗

Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01_AE and CRF07_BC virus in Guangdong Province, China.Semantic proximity Read ↗

Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.Semantic proximity Read ↗

The Dominance of CRF01_AE and the Emergence of Drug Resistance Mutations Among Antiretroviral Therapy-Experienced, HIV-1-infected Individuals in Medan, Indonesia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.